Feature Channels:

Pharmaceuticals

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Ketamine, Anesthesia & Analgesia, postoperative delirium

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 30-May-2017 6:30 PM EDT

Medicine

Channels:

Hip Replacement, Hip Replacement Surgery, Pain Managament, pain control, Acetaminophen, Opiod Pain Medications, Opiods, Joint Replacement

Study Launched to See if IV Acetaminophen Can Reduce Need for Opioid Medication After Hip Replacement Surgery

WestrichGwhitecoatJune2015.jpg

Hospital for Special Surgery has launched a study to see if intravenous (IV) acetaminophen can reduce the amount of opioid pain medicine needed after hip replacement surgery.

Medicine

Channels:

Asthma, benralizumab

New Medicine Shows Potential to Reduce Oral Steroid Use in Severe Asthma Patients

The results of the trial, published this week in the New England Journal of Medicine, demonstrate that patients treated with a potential new medicine and antibody, called benralizumab, were more than four times likely to reduce their usage of oral corticosteroids than those taking a placebo.

Medicine

Channels:

Hematology, Blood Clot, Thrombosis, Blood Thinner, Platelets

Jefferson Researcher Identifies Targets for Better Anti-Thrombotic Medicine

Blood thinners, such as aspirin, reduce the risk of thrombus formation but also interfere with the initial clot formation that is essential for preventing blood loss from the wounds. Now researchers have discovered that a molecule plays a role in thrombus development, but not the initial clot formation, suggesting a new avenue for developing more specific and protective blood thinners.

Science

Channels:

Biology, Cell Biology, Molecular Biology, Medicine & Health, Metabolic Diseases, Type 2 Diabetes, Pharmaceucticals, new drug discovery

Scientists Capture the First cryo-EM Images of Cellular Target for Type 2 Diabetes in Action

Skiniotis_figure_04_2017.jpg

Researchers at the University of Michigan, Stanford University and biotech company ConfometRx have captured the first cryo-electron microscopy snapshots of a key cellular receptor in action.

Medicine

Channels:

New Bladder Cancer Drug, Skin Cancer Facts, Advanced Stage Colorectal Cancer, and More in the Cancer News Source

Click here to go directly to the Cancer News Source

Medicine

Channels:

Practical Clinical Trials Can Help Find Alternatives to Opioids

Pressures on primary care doctors to move away from opioid pain management are increasing, but practitioners need practical, evidence-based information on how to employ multidisciplinary pain care successfully in everyday clinical practice. A senior investigator for Kaiser Permanente, speaking at the American Pain Society Annual Scientific Conference, believes wider use of practical clinical trials and more emphasis on patient self-management are key solutions for achieving wider use of multidisciplinary pain care to improve patient function and help lower use and misuse of opioids.

Medicine

Channels:

bladder, Bladder Cancer, bladder cancer clinical trial, pembrolizumab, FDA Approval, FDA approved, FDA Clearance, atezolizumab, chemo side effects, checkpoint inhibitors

Second Drug Receives FDA Approval for Bladder Cancer Based on Research Led by NYU Langone

Balar_Arjun.jpg

The U.S. Food and Drug Administration has granted accelerated approval to a second drug in less than a month for first-line treatment for advanced bladder cancer – again based on clinical trial findings from the same researcher from NYU Langone’s Perlmutter Cancer Center.

Medicine

Channels:

citrin, citrullinemia, Erez, cancer metabolism

Rare Genetic Defect May Lead to Cancer Drug

Dr. Ayelet Erez, a doctor and geneticist at the Weizmann Institute of Science, has found that while a lack of the protein citrin slows children’s growth, blocking it in cancer slows tumor growth

Medicine

Channels:

type 2 diabetes, , Type 2 Diabetes, theurapeutics, Drug Design, anti-diabetic

Designing Better Drugs to Treat Type 2 Diabetes

Research led by the University of Adelaide is paving the way for safer and more effective drugs to treat type 2 diabetes, reducing side effects and the need for insulin injections.







Chat now!